Total Artificial Heart Recipient Heads Home for the Holidays
with New Donor Heart & Kidney

Dec. 15, 2011

Last month, with the holiday season just around the corner, Jennifer Kliesing was preparing to give her husband the ultimate gift: one of her kidneys. In June, her husband Jeremiah had suffered two heart attacks and was subsequently implanted with the SynCardia temporary Total Artificial Heart at Texas Heart Institute (THI) at St. Luke's Episcopal Hospital in Houston. When Jeremiah's kidney function had not returned after several months, Jennifer had been tested and approved as a match for her husband. However, on Nov. 11, a matching donor heart and kidney became available, and Jeremiah received the dual transplant he had been waiting for... read more

Forbes Names SynCardia One of "America's Most Promising Companies"

Dec. 8, 2011

SynCardia Systems, Inc., the privately-held manufacturer of the world's only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, has been selected by Forbes as one of "America's Most Promising Companies." The list features 100 privately held up-and-comers with compelling business models, strong management teams, notable customers, strategic partners and precious investment capital. Ranked No. 77, SynCardia was the only Arizona company to make the cut... read more

SynCardia Forms European Entity to Address Growing Demand
for World's Only Approved Total Artificial Heart

Nov. 30, 2011

SynCardia Systems, Inc., manufacturer of the world's only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today it has formed SynCardia Systems Europe GmbH in Bad Oeynhausen, Germany, to address growing demand for the SynCardia temporary Total Artificial Heart in the European market. SynCardia GmbH will be led by Managing Directors Oliver Voigt, PhD and Markus Leinberger, RN... read more

USC Discharges 1st Total Artificial Heart Patient on the West Coast
Using Freedom® Portable Driver

Nov. 16, 2011

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that on Nov. 9, Keck Hospital of the University of Southern California (USC) discharged the first Total Artificial Heart patient on the West Coast to wait for a matching donor heart at home using the Freedom® portable driver... read more

1st Findings on Exercise Performance with SynCardia's Total Artificial Heart
Published in The Journal of Heart and Lung Transplantation

Nov. 10, 2011

In the November issue of The Journal of Heart and Lung Transplantation (JHLT), Virginia Commonwealth University (VCU) Medical Center in Richmond published the first findings demonstrating that physical exercise and measurable rehabilitation are feasible with the SynCardia temporary Total Artificial Heart... read more

SynCardia Honored with Membership in World Technology Network

Nov. 2, 2011

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that it has been inducted into the World Technology Network (WTN) as a new Corporate Member. Membership can only occur through the annual Awards process, in which individuals and companies are selected via the judgment of the current WTN Fellows. SynCardia was selected as one of 6 finalists for the 2011 World Technology Award in Health & Medicine, presented in association with TIME, Fortune, CNN, Science/AAAS and Technology Review... read more

Oklahoma Pastor with Total Artificial Heart Marks
1 Year of Life at Home with Freedom® Portable Driver

Oct. 27, 2011

SynCardia Systems, Inc., manufacturer of the world's only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Oklahoma pastor Troy Golden has surpassed one year of life at home using the Freedom® portable driver to power his SynCardia temporary Total Artificial Heart. Mr. Golden was discharged from INTEGRIS Baptist Medical Center in Oklahoma City on Oct. 18, 2010, to wait for a matching donor heart at home... read more

SynCardia Named "Arizona Bioscience Company of the Year"

Oct. 18, 2011

On Oct. 13, SynCardia Systems, Inc., manufacturer of the world's only FDA, Health Canada and CE approved Total Artificial Heart, was named "Arizona Bioscience Company of the Year" by the Arizona BioIndustry Association (AZBio)... read more

Texas Heart Institute Implants 4 SynCardia Total Artificial Hearts in 12 Days

Oct. 6, 2011

SynCardia Systems, Inc., manufacturer of the world's only FDA, Health Canada and CE approved Total Artificial Heart, announced today that Texas Heart Institute (THI) at St. Luke's Episcopal Hospital (SLEH) in Houston performed four implants of the SynCardia temporary Total Artificial Heart over a 12-day period beginning July 22... read more